What Underlies the Benefit of Famotidine Formulations Used During COVID-19?

Vijay P. Singh; Bara El-Kurdi; Christopher Rood

doi:10.1053/j.gastro.2020.07.051

What Underlies the Benefit of Famotidine Formulations Used During COVID-19?

Vijay P. Singh, Bara El-Kurdi, Christopher Rood

Gastroenterology and Hepatology

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	1899-1900
Number of pages	2
Journal	Gastroenterology
Volume	160
Issue number	5
DOIs	https://doi.org/10.1053/j.gastro.2020.07.051
State	Published - Apr 2021

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1053/j.gastro.2020.07.051

Cite this

@article{c2d05225e84246999f758541c64188fe,

title = "What Underlies the Benefit of Famotidine Formulations Used During COVID-19?",

author = "Singh, {Vijay P.} and Bara El-Kurdi and Christopher Rood",

year = "2021",

month = apr,

doi = "10.1053/j.gastro.2020.07.051",

language = "English (US)",

volume = "160",

pages = "1899--1900",

journal = "Gastroenterology",

issn = "0016-5085",